Pedraza Rodrigo, Aminian Ali, Nieto Javier, Faraj Chadi, Pickron T Bartley, Haas Eric M
Division of Minimally Invasive Colon and Rectal Surgery, Department of Surgery, The University of Texas Medical School at Houston, Houston, TX, USA ; Colorectal Surgical Associates, LLP, Ltd, Houston, TX 77054, USA.
Minim Invasive Surg. 2013;2013:283438. doi: 10.1155/2013/283438. Epub 2013 May 19.
Introduction. Single-incision laparoscopic colectomy (SILC) is a viable and safe technique; however, there are no single-institution studies comparing outcomes of SILC for colon cancer with well-established minimally invasive techniques. We evaluated the short-term outcomes following SILC for cancer compared to a group of well-established minimally invasive techniques. Methods. Fifty consecutive patients who underwent SILC for colon cancer were compared to a control group composed of 50 cases of minimally invasive colectomies performed with either conventional multiport or hand-assisted laparoscopic technique. The groups were paired based on the type of procedure. Demographics, intraoperative, and postoperative outcomes were assessed. Results. With the exception of BMI, demographics were similar between both groups. Most of the procedures were right colectomies (n = 33) and anterior resections (n = 12). There were no significant differences in operative time (127.9 versus 126.7 min), conversions (0 versus 1), complications (14% versus 8%), length of stay (4.5 versus 4.0 days), readmissions (2% versus 2%), and reoperations (2% versus 2%). Oncological outcomes were also similar between groups. Conclusions. SILC is an oncologically sound alternative for the management of colon cancer and results in similar short-term outcomes as compared with well-established minimally invasive techniques.
引言。单切口腹腔镜结肠切除术(SILC)是一种可行且安全的技术;然而,尚无单机构研究将结肠癌的SILC与成熟的微创技术的结果进行比较。我们评估了与一组成熟的微创技术相比,SILC治疗癌症后的短期结果。方法。将连续50例行SILC治疗结肠癌的患者与由50例采用传统多端口或手辅助腹腔镜技术进行的微创结肠切除术组成的对照组进行比较。根据手术类型对两组进行配对。评估人口统计学、术中及术后结果。结果。除体重指数外,两组的人口统计学特征相似。大多数手术为右半结肠切除术(n = 33)和前切除术(n = 12)。手术时间(127.9对126.7分钟)、中转率(0对1)、并发症(14%对8%)、住院时间(4.5对4.0天)、再入院率(2%对2%)和再次手术率(2%对2%)均无显著差异。两组的肿瘤学结果也相似。结论。SILC是结肠癌治疗中一种肿瘤学上合理的替代方法,与成熟的微创技术相比,短期结果相似。